Mounjaro™ (tirzepatide) injection

2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Tirzepatide: Congestive Heart Failure Class IV

Tirzepatide has not been studied in people with class IV congestive heart failure.


Detailed Information

There is no information on the use of tirzepatide in patients with a history of class IV congestive heart failure because patients were excluded from tirzepatide clinical trials if they had a history of class IV congestive heart failure.

Date of Last Review: March 22, 2021

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical